The stock valuation for ResMed Inc. (NYSE: RMD ) and its share price have increased despite the company’s deteriorating fundamentals. Barclays’ Matthew Taylor maintained an Underweight rating on the company, ...
- Investor's Business Daily•3 days ago
Wall Street analysts on Tuesday issued fresh buy ratings on Square and United, while downgrading Logitech International and ResMed.
ResMed Inc. (RMD)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||67.98 x 100|
|Ask||70.04 x 300|
|Day's Range||68.51 - 69.28|
|52wk Range||49.11 - 70.90|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||27.72|
|Avg Vol (3m)||881,550|
|Dividend & Yield||1.32 (1.94%)|